Lv41
430 积分 2020-07-14 加入
FIGHT‐102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies
46分钟前
已关闭
Precision oncology targeting FGFRs: A systematic review on pre-clinical activity and clinical outcomes of pemigatinib
56分钟前
求助中
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies
1小时前
已关闭
Futibatinib: First Approval
1小时前
已完结
Pemigatinib in cholangiocarcinoma with a FGFR2 rearrangement or fusion
1小时前
已完结
PBPK Modeling as an Alternative Method of Interspecies Extrapolation that Reduces the Use of Animals: A Systematic Review
6天前
已完结
The breast cancer drug market
2个月前
已完结
Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making
2个月前
已完结
Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics
2个月前
已完结
Whole-Body Disposition and Physiologically Based Pharmacokinetic Modeling of Adeno-Associated Viruses and the Transgene Product
2个月前
已完结
皖公网安备34019202002308
